Profitability Arrives as the Access Squeeze Widens — May 2026
Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates. May 2026 sharpened a new imbalance in global cannabis: profitability is finally arriving, while access is tightening at the point of care. In the United […]
Reform Tracks Diverge as Schedule III Lands — April 2026
Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates. April 2026 saw global cannabis splitting into two reform tracks running in opposite directions. The United States moved medical cannabis to Schedule III, unlocking §280E relief across […]
Global Industry Outpaces Its Regulatory Frameworks — March 2026
Access the full version of this brief with detailed access to the complete recap of the last month, as well as a curated database of market insights and regulation updates. March delivered the clearest evidence yet that the global cannabis industry is maturing faster than the regulatory frameworks governing it. Record earnings seasons in Canada and Germany […]
Consolidation Wave Reshapes Global Cannabis — February 2026
Access the full version of this brief with detailed access to the complete recap of over 300 global updates in the last month, as well as a curated database of +7,000 regulation updates, market reports and science papers. February 2026 was defined by cross-border consolidation on an unprecedented scale. Organigram acquired Sanity Group for €227M — Europe’s largest cannabis deal — […]
Commercial Highs Collide with Compliance Friction — January 2026
Access the full version of this brief with detailed access to the complete recap of over 300 global updates from January 2026, as well as a database of +6,500 regulation updates, market reports and science papers. January 2026 marked a month in which volumes hit new highs while the rules governing them lagged behind. Israel broke trade records with 30.5 […]
Historic regulatory pivots meet market caution — December 2025
Thank you for being a Cannamonitor subscriber. You have full access to this brief—over 300 December updates across 45+ markets—plus our complete searchable database of 7,000+ regulation, market and science sources: in the Insights section you’ll get access as well to the M&A Tracker mentioned below. December 2025 delivered the most significant US federal cannabis policy shift […]
Hemp Under Siege, Telemedicine Squeezed — November 2025 Brief
Hemp and CBD restrictions reshape access and redraw the global cannabis geoeconomy
Legalisation Momentum Meets Regulatory Headwinds — October 2025 Brief
Access the database with +5,000 regulation updates, market reports and science papers on the international cannabis market. October 2025 highlighted a decisive shift toward regulatory expansion across the global cannabis landscape. Import quotas rose, hospital and pharmacy access widened, and several countries advanced long-awaited legal frameworks — signalling renewed political momentum. Yet these openings coexist with […]
Regulatory scrutiny fuels market instability — September 2025 Brief
September 2025 underscored the tension between rising demand and tightening compliance across global cannabis supply chains. Imports, prescriptions, and economic contributions continue to climb, yet regulatory reviews multiply — with stricter prescribing rules and compliance crackdowns reshaping access. Some countries move boldly toward reform, while others drift in regulatory grey zones — marking a sector entering […]
Global Market Grows Under Tightening Rules – August 2025 Brief
Diverging access and mounting constraints define the next phase of global cannabis amid fragile supply chains.